ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiovascular POCT Market Research Report 2025
Published Date: May 2025
|
Report Code: QYRE-Auto-17M14028
Home | Market Reports | Health| Medical Devices & Equipment
Global Cardiovascular POCT Market Research Report 2023
BUY CHAPTERS

Global Cardiovascular POCT Market Research Report 2025

Code: QYRE-Auto-17M14028
Report
May 2025
Pages:93
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
Roche
Abbott
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Sinocare
Relia Bioengineering Co., Ltd
Assure Tech. (Hangzhou) Co., Ltd
Nanjing Vazyme Biotech Co.,Ltd.
Siemens Healthineers
Danaher
Sansure Biotech Inc
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Beijing Hotgen Biotech Co., Ltd
Biomerieux

Cardiovascular POCT Market Size

According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years.

Cardiovascular POCT Market

Cardiovascular POCT Market

The global market for Cardiovascular POCT was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Cardiovascular POCT, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Cardiovascular POCT.
The Cardiovascular POCT market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Cardiovascular POCT market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Cardiovascular POCT manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Scope of Cardiovascular POCT Market Report

Report Metric Details
Report Name Cardiovascular POCT Market
Accounted market size in year US$ 603 billion
CAGR 5%
Base Year year
Segment by Type
Segment by Application
  • Hospital
  • lndependent Testing Organization
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Roche, Abbott, BioMerieux, Wuhan Easy Diagnosis Biomedicine Co.,ltd., Guangzhou Wondfo Biotech Co.,Ltd., Getein Biotech, Inc., Sinocare Inc, Relia Bioengineering Co., Ltd, Beijing Hotgen Biotech Co.,ltd., Assure Tech (Hangzhou) Co.,Ltd., Nanjing Vazyme Biotech Co.,Ltd., Siemens Healthineers, Danaher, Sansure Biotech Inc.
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Core Chapters

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Cardiovascular POCT manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Sales, revenue of Cardiovascular POCT in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and market size of each country in the world.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 7: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 8: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 9: The main points and conclusions of the report. 

FAQ for this report

Who are the main players in the Cardiovascular POCT Market report?

Ans: The main players in the Cardiovascular POCT Market are Roche, Abbott, BioMerieux, Wuhan Easy Diagnosis Biomedicine Co.,ltd., Guangzhou Wondfo Biotech Co.,Ltd., Getein Biotech, Inc., Sinocare Inc, Relia Bioengineering Co., Ltd, Beijing Hotgen Biotech Co.,ltd., Assure Tech (Hangzhou) Co.,Ltd., Nanjing Vazyme Biotech Co.,Ltd., Siemens Healthineers, Danaher, Sansure Biotech Inc.

What are the Application segmentation covered in the Cardiovascular POCT Market report?

Ans: The Applications covered in the Cardiovascular POCT Market report are Hospital, lndependent Testing Organization

What are the Type segmentation covered in the Cardiovascular POCT Market report?

Ans: The Types covered in the Cardiovascular POCT Market report are Based on Immunochromatography, Based on Chemiluminescence Technology, Based on Biosensor, Based on Colloidal Gold, Others

Recommended Reports

Cardiovascular Devices

Cardiac Monitoring

Cardiac Interventions

1 Cardiovascular POCT Market Overview
1.1 Product Definition
1.2 Cardiovascular POCT by Type
1.2.1 Global Cardiovascular POCT Market Value Comparison by Type (2024 VS 2031)
1.2.2 Based on Immunochromatography
1.2.3 Based on Chemiluminescence Technology
1.2.4 Based on Biosensor
1.2.5 Based on Colloidal Gold
1.2.6 Others
1.3 Cardiovascular POCT by Application
1.3.1 Global Cardiovascular POCT Market Value by Application (2024 VS 2031)
1.3.2 Hospital
1.3.3 lndependent Testing Organization
1.4 Global Cardiovascular POCT Market Size Estimates and Forecasts
1.4.1 Global Cardiovascular POCT Revenue 2020-2031
1.4.2 Global Cardiovascular POCT Sales 2020-2031
1.4.3 Global Cardiovascular POCT Market Average Price (2020-2031)
1.5 Assumptions and Limitations
2 Cardiovascular POCT Market Competition by Manufacturers
2.1 Global Cardiovascular POCT Sales Market Share by Manufacturers (2020-2025)
2.2 Global Cardiovascular POCT Revenue Market Share by Manufacturers (2020-2025)
2.3 Global Cardiovascular POCT Average Price by Manufacturers (2020-2025)
2.4 Global Key Players of Cardiovascular POCT, Industry Ranking, 2022 VS 2023 VS 2024
2.5 Global Key Manufacturers of Cardiovascular POCT, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Cardiovascular POCT, Product Type & Application
2.7 Global Key Manufacturers of Cardiovascular POCT, Date of Enter into This Industry
2.8 Global Cardiovascular POCT Market Competitive Situation and Trends
2.8.1 Global Cardiovascular POCT Market Concentration Rate
2.8.2 The Global 5 and 10 Largest Cardiovascular POCT Players Market Share by Revenue
2.8.3 Global Cardiovascular POCT Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardiovascular POCT Market Scenario by Region
3.1 Global Cardiovascular POCT Market Size by Region: 2020 Versus 2024 Versus 2031
3.2 Global Cardiovascular POCT Sales by Region: 2020-2031
3.2.1 Global Cardiovascular POCT Sales by Region: 2020-2025
3.2.2 Global Cardiovascular POCT Sales by Region: 2026-2031
3.3 Global Cardiovascular POCT Revenue by Region: 2020-2031
3.3.1 Global Cardiovascular POCT Revenue by Region: 2020-2025
3.3.2 Global Cardiovascular POCT Revenue by Region: 2026-2031
3.4 North America Cardiovascular POCT Market Facts & Figures by Country
3.4.1 North America Cardiovascular POCT Market Size by Country: 2020 VS 2024 VS 2031
3.4.2 North America Cardiovascular POCT Sales by Country (2020-2031)
3.4.3 North America Cardiovascular POCT Revenue by Country (2020-2031)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardiovascular POCT Market Facts & Figures by Country
3.5.1 Europe Cardiovascular POCT Market Size by Country: 2020 VS 2024 VS 2031
3.5.2 Europe Cardiovascular POCT Sales by Country (2020-2031)
3.5.3 Europe Cardiovascular POCT Revenue by Country (2020-2031)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiovascular POCT Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiovascular POCT Market Size by Region: 2020 VS 2024 VS 2031
3.6.2 Asia Pacific Cardiovascular POCT Sales by Region (2020-2031)
3.6.3 Asia Pacific Cardiovascular POCT Revenue by Region (2020-2031)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cardiovascular POCT Market Facts & Figures by Country
3.7.1 Latin America Cardiovascular POCT Market Size by Country: 2020 VS 2024 VS 2031
3.7.2 Latin America Cardiovascular POCT Sales by Country (2020-2031)
3.7.3 Latin America Cardiovascular POCT Revenue by Country (2020-2031)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.8 Middle East and Africa Cardiovascular POCT Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiovascular POCT Market Size by Country: 2020 VS 2024 VS 2031
3.8.2 Middle East and Africa Cardiovascular POCT Sales by Country (2020-2031)
3.8.3 Middle East and Africa Cardiovascular POCT Revenue by Country (2020-2031)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiovascular POCT Sales by Type (2020-2031)
4.1.1 Global Cardiovascular POCT Sales by Type (2020-2025)
4.1.2 Global Cardiovascular POCT Sales by Type (2026-2031)
4.1.3 Global Cardiovascular POCT Sales Market Share by Type (2020-2031)
4.2 Global Cardiovascular POCT Revenue by Type (2020-2031)
4.2.1 Global Cardiovascular POCT Revenue by Type (2020-2025)
4.2.2 Global Cardiovascular POCT Revenue by Type (2026-2031)
4.2.3 Global Cardiovascular POCT Revenue Market Share by Type (2020-2031)
4.3 Global Cardiovascular POCT Price by Type (2020-2031)
5 Segment by Application
5.1 Global Cardiovascular POCT Sales by Application (2020-2031)
5.1.1 Global Cardiovascular POCT Sales by Application (2020-2025)
5.1.2 Global Cardiovascular POCT Sales by Application (2026-2031)
5.1.3 Global Cardiovascular POCT Sales Market Share by Application (2020-2031)
5.2 Global Cardiovascular POCT Revenue by Application (2020-2031)
5.2.1 Global Cardiovascular POCT Revenue by Application (2020-2025)
5.2.2 Global Cardiovascular POCT Revenue by Application (2026-2031)
5.2.3 Global Cardiovascular POCT Revenue Market Share by Application (2020-2031)
5.3 Global Cardiovascular POCT Price by Application (2020-2031)
6 Key Companies Profiled
6.1 Roche
6.1.1 Roche Company Information
6.1.2 Roche Description and Business Overview
6.1.3 Roche Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.1.4 Roche Cardiovascular POCT Product Portfolio
6.1.5 Roche Recent Developments/Updates
6.2 Abbott
6.2.1 Abbott Company Information
6.2.2 Abbott Description and Business Overview
6.2.3 Abbott Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.2.4 Abbott Cardiovascular POCT Product Portfolio
6.2.5 Abbott Recent Developments/Updates
6.3 BioMerieux
6.3.1 BioMerieux Company Information
6.3.2 BioMerieux Description and Business Overview
6.3.3 BioMerieux Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.3.4 BioMerieux Cardiovascular POCT Product Portfolio
6.3.5 BioMerieux Recent Developments/Updates
6.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd.
6.4.1 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
6.4.2 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Description and Business Overview
6.4.3 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.4.4 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Product Portfolio
6.4.5 Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
6.5 Guangzhou Wondfo Biotech Co.,Ltd.
6.5.1 Guangzhou Wondfo Biotech Co.,Ltd. Company Information
6.5.2 Guangzhou Wondfo Biotech Co.,Ltd. Description and Business Overview
6.5.3 Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.5.4 Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Product Portfolio
6.5.5 Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
6.6 Getein Biotech, Inc.
6.6.1 Getein Biotech, Inc. Company Information
6.6.2 Getein Biotech, Inc. Description and Business Overview
6.6.3 Getein Biotech, Inc. Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.6.4 Getein Biotech, Inc. Cardiovascular POCT Product Portfolio
6.6.5 Getein Biotech, Inc. Recent Developments/Updates
6.7 Sinocare Inc
6.7.1 Sinocare Inc Company Information
6.7.2 Sinocare Inc Description and Business Overview
6.7.3 Sinocare Inc Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.7.4 Sinocare Inc Cardiovascular POCT Product Portfolio
6.7.5 Sinocare Inc Recent Developments/Updates
6.8 Relia Bioengineering Co., Ltd
6.8.1 Relia Bioengineering Co., Ltd Company Information
6.8.2 Relia Bioengineering Co., Ltd Description and Business Overview
6.8.3 Relia Bioengineering Co., Ltd Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.8.4 Relia Bioengineering Co., Ltd Cardiovascular POCT Product Portfolio
6.8.5 Relia Bioengineering Co., Ltd Recent Developments/Updates
6.9 Beijing Hotgen Biotech Co.,ltd.
6.9.1 Beijing Hotgen Biotech Co.,ltd. Company Information
6.9.2 Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
6.9.3 Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.9.4 Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Product Portfolio
6.9.5 Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
6.10 Assure Tech (Hangzhou) Co.,Ltd.
6.10.1 Assure Tech (Hangzhou) Co.,Ltd. Company Information
6.10.2 Assure Tech (Hangzhou) Co.,Ltd. Description and Business Overview
6.10.3 Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.10.4 Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Product Portfolio
6.10.5 Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
6.11 Nanjing Vazyme Biotech Co.,Ltd.
6.11.1 Nanjing Vazyme Biotech Co.,Ltd. Company Information
6.11.2 Nanjing Vazyme Biotech Co.,Ltd. Description and Business Overview
6.11.3 Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.11.4 Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Product Portfolio
6.11.5 Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
6.12 Siemens Healthineers
6.12.1 Siemens Healthineers Company Information
6.12.2 Siemens Healthineers Description and Business Overview
6.12.3 Siemens Healthineers Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.12.4 Siemens Healthineers Cardiovascular POCT Product Portfolio
6.12.5 Siemens Healthineers Recent Developments/Updates
6.13 Danaher
6.13.1 Danaher Company Information
6.13.2 Danaher Description and Business Overview
6.13.3 Danaher Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.13.4 Danaher Cardiovascular POCT Product Portfolio
6.13.5 Danaher Recent Developments/Updates
6.14 Sansure Biotech Inc.
6.14.1 Sansure Biotech Inc. Company Information
6.14.2 Sansure Biotech Inc. Description and Business Overview
6.14.3 Sansure Biotech Inc. Cardiovascular POCT Sales, Revenue and Gross Margin (2020-2025)
6.14.4 Sansure Biotech Inc. Cardiovascular POCT Product Portfolio
6.14.5 Sansure Biotech Inc. Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiovascular POCT Industry Chain Analysis
7.2 Cardiovascular POCT Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiovascular POCT Production Mode & Process Analysis
7.4 Cardiovascular POCT Sales and Marketing
7.4.1 Cardiovascular POCT Sales Channels
7.4.2 Cardiovascular POCT Distributors
7.5 Cardiovascular POCT Customer Analysis
8 Cardiovascular POCT Market Dynamics
8.1 Cardiovascular POCT Industry Trends
8.2 Cardiovascular POCT Market Drivers
8.3 Cardiovascular POCT Market Challenges
8.4 Cardiovascular POCT Market Restraints
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
FEATURED COMPANIES
Roche
Abbott
Wuhan Easy Diagnosis Biomedicine Co.,Ltd.
Sinocare
Relia Bioengineering Co., Ltd
Assure Tech. (Hangzhou) Co., Ltd
Nanjing Vazyme Biotech Co.,Ltd.
Siemens Healthineers
Danaher
Sansure Biotech Inc
Guangzhou Wondfo Biotech Co.,Ltd.
Getein Biotech, Inc.
Beijing Hotgen Biotech Co., Ltd
Biomerieux
List of Tables
 Table 1. Global Cardiovascular POCT Market Value Comparison by Type (2024 VS 2031) & (US$ Million)
 Table 2. Global Cardiovascular POCT Market Value by Application (2024 VS 2031) & (US$ Million)
 Table 3. Global Cardiovascular POCT Market Competitive Situation by Manufacturers in 2024
 Table 4. Global Cardiovascular POCT Sales (K Units) of Key Manufacturers (2020-2025)
 Table 5. Global Cardiovascular POCT Sales Market Share by Manufacturers (2020-2025)
 Table 6. Global Cardiovascular POCT Revenue (US$ Million) by Manufacturers (2020-2025)
 Table 7. Global Cardiovascular POCT Revenue Share by Manufacturers (2020-2025)
 Table 8. Global Market Cardiovascular POCT Average Price (US$/Unit) of Key Manufacturers (2020-2025)
 Table 9. Global Key Players of Cardiovascular POCT, Industry Ranking, 2022 VS 2023 VS 2024
 Table 10. Global Key Manufacturers of Cardiovascular POCT, Manufacturing Sites & Headquarters
 Table 11. Global Key Manufacturers of Cardiovascular POCT, Product Type & Application
 Table 12. Global Key Manufacturers of Cardiovascular POCT, Date of Enter into This Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cardiovascular POCT by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Cardiovascular POCT as of 2024)
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cardiovascular POCT Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 17. Global Cardiovascular POCT Sales by Region (2020-2025) & (K Units)
 Table 18. Global Cardiovascular POCT Sales Market Share by Region (2020-2025)
 Table 19. Global Cardiovascular POCT Sales by Region (2026-2031) & (K Units)
 Table 20. Global Cardiovascular POCT Sales Market Share by Region (2026-2031)
 Table 21. Global Cardiovascular POCT Revenue by Region (2020-2025) & (US$ Million)
 Table 22. Global Cardiovascular POCT Revenue Market Share by Region (2020-2025)
 Table 23. Global Cardiovascular POCT Revenue by Region (2026-2031) & (US$ Million)
 Table 24. Global Cardiovascular POCT Revenue Market Share by Region (2026-2031)
 Table 25. North America Cardiovascular POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 26. North America Cardiovascular POCT Sales by Country (2020-2025) & (K Units)
 Table 27. North America Cardiovascular POCT Sales by Country (2026-2031) & (K Units)
 Table 28. North America Cardiovascular POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 29. North America Cardiovascular POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 30. Europe Cardiovascular POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 31. Europe Cardiovascular POCT Sales by Country (2020-2025) & (K Units)
 Table 32. Europe Cardiovascular POCT Sales by Country (2026-2031) & (K Units)
 Table 33. Europe Cardiovascular POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 34. Europe Cardiovascular POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 35. Asia Pacific Cardiovascular POCT Revenue by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 36. Asia Pacific Cardiovascular POCT Sales by Region (2020-2025) & (K Units)
 Table 37. Asia Pacific Cardiovascular POCT Sales by Region (2026-2031) & (K Units)
 Table 38. Asia Pacific Cardiovascular POCT Revenue by Region (2020-2025) & (US$ Million)
 Table 39. Asia Pacific Cardiovascular POCT Revenue by Region (2026-2031) & (US$ Million)
 Table 40. Latin America Cardiovascular POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Latin America Cardiovascular POCT Sales by Country (2020-2025) & (K Units)
 Table 42. Latin America Cardiovascular POCT Sales by Country (2026-2031) & (K Units)
 Table 43. Latin America Cardiovascular POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 44. Latin America Cardiovascular POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 45. Middle East and Africa Cardiovascular POCT Revenue by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Middle East and Africa Cardiovascular POCT Sales by Country (2020-2025) & (K Units)
 Table 47. Middle East and Africa Cardiovascular POCT Sales by Country (2026-2031) & (K Units)
 Table 48. Middle East and Africa Cardiovascular POCT Revenue by Country (2020-2025) & (US$ Million)
 Table 49. Middle East and Africa Cardiovascular POCT Revenue by Country (2026-2031) & (US$ Million)
 Table 50. Global Cardiovascular POCT Sales (K Units) by Type (2020-2025)
 Table 51. Global Cardiovascular POCT Sales (K Units) by Type (2026-2031)
 Table 52. Global Cardiovascular POCT Sales Market Share by Type (2020-2025)
 Table 53. Global Cardiovascular POCT Sales Market Share by Type (2026-2031)
 Table 54. Global Cardiovascular POCT Revenue (US$ Million) by Type (2020-2025)
 Table 55. Global Cardiovascular POCT Revenue (US$ Million) by Type (2026-2031)
 Table 56. Global Cardiovascular POCT Revenue Market Share by Type (2020-2025)
 Table 57. Global Cardiovascular POCT Revenue Market Share by Type (2026-2031)
 Table 58. Global Cardiovascular POCT Price (US$/Unit) by Type (2020-2025)
 Table 59. Global Cardiovascular POCT Price (US$/Unit) by Type (2026-2031)
 Table 60. Global Cardiovascular POCT Sales (K Units) by Application (2020-2025)
 Table 61. Global Cardiovascular POCT Sales (K Units) by Application (2026-2031)
 Table 62. Global Cardiovascular POCT Sales Market Share by Application (2020-2025)
 Table 63. Global Cardiovascular POCT Sales Market Share by Application (2026-2031)
 Table 64. Global Cardiovascular POCT Revenue (US$ Million) by Application (2020-2025)
 Table 65. Global Cardiovascular POCT Revenue (US$ Million) by Application (2026-2031)
 Table 66. Global Cardiovascular POCT Revenue Market Share by Application (2020-2025)
 Table 67. Global Cardiovascular POCT Revenue Market Share by Application (2026-2031)
 Table 68. Global Cardiovascular POCT Price (US$/Unit) by Application (2020-2025)
 Table 69. Global Cardiovascular POCT Price (US$/Unit) by Application (2026-2031)
 Table 70. Roche Company Information
 Table 71. Roche Description and Business Overview
 Table 72. Roche Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 73. Roche Cardiovascular POCT Product
 Table 74. Roche Recent Developments/Updates
 Table 75. Abbott Company Information
 Table 76. Abbott Description and Business Overview
 Table 77. Abbott Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 78. Abbott Cardiovascular POCT Product
 Table 79. Abbott Recent Developments/Updates
 Table 80. BioMerieux Company Information
 Table 81. BioMerieux Description and Business Overview
 Table 82. BioMerieux Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 83. BioMerieux Cardiovascular POCT Product
 Table 84. BioMerieux Recent Developments/Updates
 Table 85. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Company Information
 Table 86. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Description and Business Overview
 Table 87. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 88. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Cardiovascular POCT Product
 Table 89. Wuhan Easy Diagnosis Biomedicine Co.,ltd. Recent Developments/Updates
 Table 90. Guangzhou Wondfo Biotech Co.,Ltd. Company Information
 Table 91. Guangzhou Wondfo Biotech Co.,Ltd. Description and Business Overview
 Table 92. Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 93. Guangzhou Wondfo Biotech Co.,Ltd. Cardiovascular POCT Product
 Table 94. Guangzhou Wondfo Biotech Co.,Ltd. Recent Developments/Updates
 Table 95. Getein Biotech, Inc. Company Information
 Table 96. Getein Biotech, Inc. Description and Business Overview
 Table 97. Getein Biotech, Inc. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 98. Getein Biotech, Inc. Cardiovascular POCT Product
 Table 99. Getein Biotech, Inc. Recent Developments/Updates
 Table 100. Sinocare Inc Company Information
 Table 101. Sinocare Inc Description and Business Overview
 Table 102. Sinocare Inc Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 103. Sinocare Inc Cardiovascular POCT Product
 Table 104. Sinocare Inc Recent Developments/Updates
 Table 105. Relia Bioengineering Co., Ltd Company Information
 Table 106. Relia Bioengineering Co., Ltd Description and Business Overview
 Table 107. Relia Bioengineering Co., Ltd Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 108. Relia Bioengineering Co., Ltd Cardiovascular POCT Product
 Table 109. Relia Bioengineering Co., Ltd Recent Developments/Updates
 Table 110. Beijing Hotgen Biotech Co.,ltd. Company Information
 Table 111. Beijing Hotgen Biotech Co.,ltd. Description and Business Overview
 Table 112. Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 113. Beijing Hotgen Biotech Co.,ltd. Cardiovascular POCT Product
 Table 114. Beijing Hotgen Biotech Co.,ltd. Recent Developments/Updates
 Table 115. Assure Tech (Hangzhou) Co.,Ltd. Company Information
 Table 116. Assure Tech (Hangzhou) Co.,Ltd. Description and Business Overview
 Table 117. Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 118. Assure Tech (Hangzhou) Co.,Ltd. Cardiovascular POCT Product
 Table 119. Assure Tech (Hangzhou) Co.,Ltd. Recent Developments/Updates
 Table 120. Nanjing Vazyme Biotech Co.,Ltd. Company Information
 Table 121. Nanjing Vazyme Biotech Co.,Ltd. Description and Business Overview
 Table 122. Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 123. Nanjing Vazyme Biotech Co.,Ltd. Cardiovascular POCT Product
 Table 124. Nanjing Vazyme Biotech Co.,Ltd. Recent Developments/Updates
 Table 125. Siemens Healthineers Company Information
 Table 126. Siemens Healthineers Description and Business Overview
 Table 127. Siemens Healthineers Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 128. Siemens Healthineers Cardiovascular POCT Product
 Table 129. Siemens Healthineers Recent Developments/Updates
 Table 130. Danaher Company Information
 Table 131. Danaher Description and Business Overview
 Table 132. Danaher Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 133. Danaher Cardiovascular POCT Product
 Table 134. Danaher Recent Developments/Updates
 Table 135. Sansure Biotech Inc. Company Information
 Table 136. Sansure Biotech Inc. Description and Business Overview
 Table 137. Sansure Biotech Inc. Cardiovascular POCT Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)
 Table 138. Sansure Biotech Inc. Cardiovascular POCT Product
 Table 139. Sansure Biotech Inc. Recent Developments/Updates
 Table 140. Key Raw Materials Lists
 Table 141. Raw Materials Key Suppliers Lists
 Table 142. Cardiovascular POCT Distributors List
 Table 143. Cardiovascular POCT Customers List
 Table 144. Cardiovascular POCT Market Trends
 Table 145. Cardiovascular POCT Market Drivers
 Table 146. Cardiovascular POCT Market Challenges
 Table 147. Cardiovascular POCT Market Restraints
 Table 148. Research Programs/Design for This Report
 Table 149. Key Data Information from Secondary Sources
 Table 150. Key Data Information from Primary Sources
 Table 151. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cardiovascular POCT
 Figure 2. Global Cardiovascular POCT Market Value Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Cardiovascular POCT Market Share by Type: 2024 & 2031
 Figure 4. Based on Immunochromatography Product Picture
 Figure 5. Based on Chemiluminescence Technology Product Picture
 Figure 6. Based on Biosensor Product Picture
 Figure 7. Based on Colloidal Gold Product Picture
 Figure 8. Others Product Picture
 Figure 9. Global Cardiovascular POCT Market Value by Application (2020-2031) & (US$ Million)
 Figure 10. Global Cardiovascular POCT Market Share by Application: 2024 & 2031
 Figure 11. Hospital
 Figure 12. lndependent Testing Organization
 Figure 13. Global Cardiovascular POCT Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 14. Global Cardiovascular POCT Market Size (2020-2031) & (US$ Million)
 Figure 15. Global Cardiovascular POCT Sales (2020-2031) & (K Units)
 Figure 16. Global Cardiovascular POCT Average Price (US$/Unit) & (2020-2031)
 Figure 17. Cardiovascular POCT Report Years Considered
 Figure 18. Cardiovascular POCT Sales Share by Manufacturers in 2024
 Figure 19. Global Cardiovascular POCT Revenue Share by Manufacturers in 2024
 Figure 20. Global 5 and 10 Largest Cardiovascular POCT Players: Market Share by Revenue in Cardiovascular POCT in 2024
 Figure 21. Cardiovascular POCT Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2020 VS 2024
 Figure 22. Global Cardiovascular POCT Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Figure 23. North America Cardiovascular POCT Sales Market Share by Country (2020-2031)
 Figure 24. North America Cardiovascular POCT Revenue Market Share by Country (2020-2031)
 Figure 25. United States Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 26. Canada Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 27. Europe Cardiovascular POCT Sales Market Share by Country (2020-2031)
 Figure 28. Europe Cardiovascular POCT Revenue Market Share by Country (2020-2031)
 Figure 29. Germany Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 30. France Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 31. U.K. Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 32. Italy Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 33. Russia Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 34. Asia Pacific Cardiovascular POCT Sales Market Share by Region (2020-2031)
 Figure 35. Asia Pacific Cardiovascular POCT Revenue Market Share by Region (2020-2031)
 Figure 36. China Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 37. Japan Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 38. South Korea Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 39. India Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 40. Australia Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 41. China Taiwan Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 42. Southeast Asia Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 43. Latin America Cardiovascular POCT Sales Market Share by Country (2020-2031)
 Figure 44. Latin America Cardiovascular POCT Revenue Market Share by Country (2020-2031)
 Figure 45. Mexico Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 46. Brazil Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 47. Argentina Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 48. Middle East and Africa Cardiovascular POCT Sales Market Share by Country (2020-2031)
 Figure 49. Middle East and Africa Cardiovascular POCT Revenue Market Share by Country (2020-2031)
 Figure 50. Turkey Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 51. Saudi Arabia Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 52. UAE Cardiovascular POCT Revenue Growth Rate (2020-2031) & (US$ Million)
 Figure 53. Global Sales Market Share of Cardiovascular POCT by Type (2020-2031)
 Figure 54. Global Revenue Market Share of Cardiovascular POCT by Type (2020-2031)
 Figure 55. Global Cardiovascular POCT Price (US$/Unit) by Type (2020-2031)
 Figure 56. Global Sales Market Share of Cardiovascular POCT by Application (2020-2031)
 Figure 57. Global Revenue Market Share of Cardiovascular POCT by Application (2020-2031)
 Figure 58. Global Cardiovascular POCT Price (US$/Unit) by Application (2020-2031)
 Figure 59. Cardiovascular POCT Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Nano Dimension

SIMILAR REPORTS

Point of care Testing POCT for Cardiovascular Diseases Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Coagulation POCT Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Sutures Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Repair Patch Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiovascular Surgery Devices Market Research Report 2024
Global Cardiac Medical Devices Market Research Report 2024
Cardiovascular Digital Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Interventional Cardiovascular Device Market Research Report 2025
Global Diagnostic Monitoring Devices for Cardiovascular Market Insights Forecast to 2030
Cardiovascular Medical Device and Diagnostics Trials Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Proximal Anastomosis Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiac Surgery Devices Market Research Report 2024
Cardiac Diagnostics and Monitoring Equipment Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Heart Valve Medical Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Intervention Robot Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Point of care Devices Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Disease Test Kit Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Cardiovascular Diagnostic and Monitoring Devices Market Insights Forecast to 2030
Cardiac Event Monitors Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Cardiovascular Clinical Imaging Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

RELATED REPORTS

Global Surgical Waste Management Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-16G6108
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global PET-CT Scanning Services Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-27Q5892
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Micromanipulation Pipettes for IVF Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14K19926
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Nebulizer Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-15N17310
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions